Muhammed Kashif Riaz

4PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 25, 2026
A Phase 2 Feasibility Study Combining Pembrolizumab and Metformin in patients with Metastatic Head and Neck Cancer.

|May 16, 2025
Phase II Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Olga Zamulko, Vidhya Karivedu, Muhammad Kashif Riaz

|Feb 21, 2023
Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial.

Shuchi Gulati, McKenzie Crist, Muhammed Kashif Riaz

|Oct 19, 2019
Phase 1 dose-finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer.

Shuchi Gulati, Janki Desai, Sarah M Palackdharry

Pageof 1

Frequent Collaborators

4 joint publications

Trisha Wise-Draper

3 joint publications

Vinita Takiar

3 joint publications

Ilaina Monroe

2 joint publications

Shuchi Gulati